Sai Life Sciences Limited (NSE:SAILIFE)

India flag India · Delayed Price · Currency is INR
920.65
+5.80 (0.63%)
At close: Feb 16, 2026
Market Cap194.84B +43.5%
Revenue (ttm)21.70B +39.6%
Net Income3.33B +141.3%
EPS15.54 +111.9%
Shares Out211.63M
PE Ratio59.26
Forward PE48.42
Dividendn/a
Ex-Dividend Daten/a
Volume353,575
Average Volume745,988
Open919.70
Previous Close914.85
Day's Range905.60 - 928.45
52-Week Range636.10 - 983.35
Betan/a
RSI57.23
Earnings DateFeb 5, 2026

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India. [Read more]

Sector Healthcare
Founded 1999
Employees 3,401
Stock Exchange National Stock Exchange of India
Ticker Symbol SAILIFE
Full Company Profile

Financial Performance

In fiscal year 2025, Sai Life Sciences's revenue was 16.95 billion, an increase of 15.66% compared to the previous year's 14.65 billion. Earnings were 1.70 billion, an increase of 105.45%.

Financial Statements